DeepGene damage signature
SyntheticSynthetic demo data2 samples: baseline day 0 · retest day 90
Damage score · retest day 90
88/100
vs baseline (day 0)
+12
1 improved · 11 worsened
synthetic signature · consistent with this patient's biology
- 5 opportunists above range: Escherichia coli, Klebsiella pneumoniae, Enterococcus faecium
- 6 keystone species absent
- Shannon 1.58 (expected ≥ 3)
- 10 resistance genes
- Host DNA fragmentation atypical
- Tissue recycling index 61
Pathogens / opportunists5/5
Keystone species6/8
↑ from 4
Diversity2/2
Metabolic modules1/4
Vitamin synthesis6/7
↑ from 4
Oral translocation1/1
Host DNA1/1
↑ from 0
Tissue recycling1/1
Central mechanisms2/2
↑ from 1
Species dominance1/1
Virulence factors6/6
↑ from 4
Antibiotic resistance genes10/10
↑ from 8
Genetic predisposition2/2
Opportunists above range
Escherichia coli 33.687% AR
Enterococcus faecium 16.843% AR
Klebsiella pneumoniae 10.106% AR
Streptococcus gallolyticus 3.369% AR
Keystone species absent
Akkermansia muciniphila, Bifidobacterium longum, Butyricicoccus pullicaecorum, Eubacterium rectale, Faecalibacterium prausnitzii
Capacity
Shannon 1.58 · butyrate 304 CPM · SCFA 553
H2S above band
6 vitamins below
Host & mechanisms
host DNA fragmentation atypical
tissue recycling 61/100
oral translocation 7.63% AR
molecular_mimicry above
estrobolome above
10 resistance genes · 6 virulence factors
Import a sample
A baseline sample re-initializes this patient's microbiome, pathways and predispositions from the measurement; a retest adds a comparison and updates them. Every theory, steering gain and dietary sensitivity downstream is then conditioned on the measured signature.
All elements · baseline → latest
Value, status vs the expected range, and the implication on health. Changes coloured: green improved / resolved, red worsened / new.
Pathogens / opportunists · 5
| Escherichia coli | 22.099 % AR · above range | 33.687 % AR · above range | expected <= 1% | In excess raises LPS load and zonulin release, opening tight junctions. |
| Klebsiella pneumoniae | 6.63 % AR · above range | 10.106 % AR · above range | expected <= 0.3% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Enterococcus faecium | 11.049 % AR · above range | 16.843 % AR · above range | expected <= 0.5% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Streptococcus gallolyticus | 2.21 % AR · above range | 3.369 % AR · above range | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Clostridioides difficile | 2.21 % AR · above range | 3.369 % AR · above range | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
Keystone species · 8
| Akkermansia muciniphila | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Bifidobacterium longum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Butyricicoccus pullicaecorum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Eubacterium rectale | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Faecalibacterium prausnitzii | 0.01 % AR · in range | 0 % AR · absent(worsened) | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Lactobacillus species | 0.78 % AR · in range | 0 % AR · absent(worsened) | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Roseburia intestinalis | 1.06 % AR · in range | 0.14 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Ruminococcus bromii | 0.49 % AR · in range | 1.21 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
Diversity · 2
| indice Shannon | 2.53 · below range | 1.58 · below range | expected >= 3.0 | Low diversity: fewer reserve metabolic routes, slower recovery after perturbation. |
| numar de specii detectate | 89 specii · below range | 55 specii · below range | expected >= 100 | Species count below reference. |
Metabolic modules · 4
| Butyrate production | 512 CPM · in range | 304 CPM · in range | expected 255.83-1089.91 CPM | Butyrate is the main colonocyte fuel and barrier signal. |
| Short Chain Fatty Acid Production | 909 CPM · in range | 553 CPM · in range | expected 535.03-1572.59 CPM | Total SCFA capacity. |
| GABA production | 267 CPM · in range | 139 CPM · in range | expected 87.31-766.53 CPM | Gut–brain axis capacity. |
| H2S production (sulfate reduction) | 304 CPM · above range | 477 CPM · above range | expected banda de referinta | Hydrogen sulfide above band irritates the mucosa. |
Vitamin synthesis · 7
| Vitamin B1 - Thiamin | 169 CPM · below range | 225 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B2 - Riboflavin | 286 CPM · below range | 164 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B5 - Pantothenic acid | 304 CPM · below range | 195 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B6 - Pyridoxine | 465 CPM · below range | 248 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B7 - Biotin | 3779 CPM · in range | 480 CPM · below range(worsened) | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B9 - Folate | 4429 CPM · in range | 434 CPM · below range(worsened) | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B12 - Cobalamin | 4302 CPM · in range | 4379 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
Oral translocation · 1
| Translocare orala (indice) | 5.02 % AR · above range | 7.63 % AR · above range | expected <= 2% | Oral taxa in stool: reduced gastric barrier or dysbiosis. |
Host DNA · 1
| fragmentare mixta | 166 pb · in range | 202 pb · atypical(worsened) | expected 150-170 pb | Host cell-free DNA fragmentation pattern. |
Tissue recycling · 1
| indice de reciclare tisulara | 43 /100 · above range | 61 /100 · above range | expected < 35 | Epithelial turnover. |
Central mechanisms · 2
| molecular_mimicry | 65 /100 · in range | 77 /100 · above range(worsened) | expected < 65 | Cross-reactive antigen load. |
| estrobolome | 69 /100 · above range | 76 /100 · above range | expected < 65 | Estrogen-recycling capacity. |
Species dominance · 2
| Bifidobacterium breve | 38.84 % AR · above range | resolved(resolved) | expected < 20% per specie | One species occupies the niche of others. |
| Escherichia coli | — | 30.85 % AR · above range(new) | expected < 20% per specie | One species occupies the niche of others. |
Virulence factors · 6
| fimD outer membrane usher | 69 potriviri/M · present | 38 potriviri/M · present | expected absent | Virulence factor detected. |
| chuA heme/hemoglobin receptor | 91 potriviri/M · present | 54 potriviri/M · present | expected absent | Virulence factor detected. |
| irp2 yersiniabactin synthetase | 53 potriviri/M · present | 50 potriviri/M · present | expected absent | Virulence factor detected. |
| espX4 type III secretion | 41 potriviri/M · present | 98 potriviri/M · present | expected absent | Virulence factor detected. |
| kpsD polysialic acid transport | — | 84 potriviri/M · present(new) | expected absent | Virulence factor detected. |
| acrB acriflavine resistance | — | 59 potriviri/M · present(new) | expected absent | Virulence factor detected. |
Antibiotic resistance genes · 10
| sul1 | 7.7 citiri/M · present | 1.7 citiri/M · present | expected nedetectat | Resistance gene detected. |
| sul2 | 2 citiri/M · present | 6.5 citiri/M · present | expected nedetectat | Resistance gene detected. |
| tet(O/M/O) | 3.6 citiri/M · present | 4 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Ecol_ampC_BLA | 9.9 citiri/M · present | 5.3 citiri/M · present | expected nedetectat | Resistance gene detected. |
| aadA | 2.6 citiri/M · present | 2.8 citiri/M · present | expected nedetectat | Resistance gene detected. |
| dfrA1 | 8.3 citiri/M · present | 6.7 citiri/M · present | expected nedetectat | Resistance gene detected. |
| APH(6)-Id | 3.1 citiri/M · present | 11 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Erm(49) | 7.5 citiri/M · present | 6.3 citiri/M · present | expected nedetectat | Resistance gene detected. |
| msrC | — | 1.4 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
| eptB | — | 10.2 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
Genetic predisposition · 2
| FUT2 | 3.42 OR · risk variant | 2.53 OR · risk variant | expected reference genotype | Reduced mucosal fucosylation |
| IL6 | 2.03 OR · risk variant | 1.82 OR · risk variant | expected reference genotype | Higher inflammatory tone |